Fundraising FoxEdiGene
13 known investors
Find your way into EdiGene
Sign up to see every warm intro you have to EdiGene
- Paths you didn't know you had: your email and LinkedIn already hold routes to the EdiGene team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
EdiGene is a biotechnology company developing genome-editing-based therapies, including allogeneic cell therapies and in vivo RNA base editing platforms, alongside a high-throughput genome editing screening platform. It focuses on treatments for genetic diseases and cancer.
Investors · 13
How we know: funding news · the VCSheet dataset · Not right? Tell us
How we know: WI Harper Group's portfolio page · Not right? Tell us
How we know: globalgenes.org · Not right? Tell us
How we know: globalgenes.org · Not right? Tell us
Also in the syndicate · 4
Funding
SEC filings, press & company announcements$62M disclosed across 1 of 3 rounds · 2018–2021
- $62Mseries B-plus financing roundApr 2021 · 4 sources
Loyal Valley Capital (lead), 3H Health Investment, Alwin Capital, BioTrack Capital, Huagai Capital, IDG Capital, Kunlun Capital, Lilly Asia Venture, Sequoia Capital China, Sherpa Healthcare Partners
Source ↗ - Undisclosed amountSeries pre-BAug 2018Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Frequently asked questions
- What does EdiGene do?
- EdiGene is a biotechnology company developing genome-editing-based therapies, including allogeneic cell therapies and in vivo RNA base editing platforms, alongside a high-throughput genome editing screening platform. It focuses on treatments for genetic diseases and cancer.
- Who are EdiGene's investors?
- EdiGene's investors include LAV, Lilly Asia Ventures, WI Harper Group, 3H Health Investment, Alwin Capital, BioTrack Capital, IDG Capital, Kunlun Capital and 1 more.
- How much funding has EdiGene raised?
- EdiGene has disclosed $62M raised across 1 of its 3 known rounds.